Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,249 | 118,697 | 107,611 | 111,209 | 129,558 |
| Receivables | 66,036 | 9,969 | 5,823 | 4,877 | 3,349 |
| Inventories | 7,902 | 1,813 | 1,401 | 1,520 | 1,495 |
| TOTAL | $207,713 | $133,484 | $118,896 | $120,615 | $136,466 |
| Non-Current Assets | |||||
| PPE Net | 1,612 | 1,826 | 1,632 | 1,583 | 1,007 |
| Intangibles | 486,100 | 0 | 1,877 | 1,925 | 1,973 |
| Other Non-Current Assets | 853 | 258 | 268 | 392 | 402 |
| TOTAL | $488,565 | $2,084 | $3,777 | $3,900 | $3,382 |
| Total Assets | $696,278 | $135,568 | $122,673 | $124,515 | $139,848 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 131,056 | 1,479 | 2,146 | 2,389 | 2,556 |
| Accounts payable and accrued liabilities | 9,336 | 5,684 | 4,982 | 5,612 | 6,793 |
| Accrued Expenses | 109,836 | 24,325 | 19,268 | 10,199 | 6,488 |
| TOTAL | $250,228 | $31,488 | $26,396 | $28,561 | $24,532 |
| Non-Current Liabilities | |||||
| Long Term Debt | 355,227 | N/A | 0 | 424 | 924 |
| Deferred Revenues | N/A | N/A | N/A | 10,361 | 8,695 |
| Other Non-Current Liabilities | 0 | 0 | 8 | 17 | 25 |
| TOTAL | $355,227 | $N/A | $8 | $441 | $949 |
| Total Liabilities | $605,455 | $31,488 | $26,404 | $29,002 | $25,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,044 | 32,994 | 32,562 | 29,567 | 29,459 |
| Common Shares | 33 | 33 | 31 | 30 | 29 |
| Retained earnings | -316,701 | -298,049 | -280,646 | -267,383 | -246,262 |
| TOTAL | $90,823 | $104,080 | $96,269 | $95,513 | $114,367 |
| Total Liabilities And Equity | $696,278 | $135,568 | $122,673 | $124,515 | $139,848 |